US SB41 | 2017-2018 | 115th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 13-1)
Status: Introduced on January 5 2017 - 25% progression, died in committee
Action: 2017-01-05 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Medicare Prescription Drug Price Negotiation Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Medicare Prescription Drug Price Negotiation Act of 2017

Sponsors


History

DateChamberAction
2017-01-05SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

HB242 (Same As) 2017-01-25 - Referred to the Subcommittee on Health.
SB1688 (Related) 2017-08-01 - Read twice and referred to the Committee on Finance.
HB3748 (Related) 2017-09-15 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback